People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other, Other Health Care, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emboline Inc | — | Other | Series C | $66.9M | $795.9M | 2020 |
| Vascular Pathways Inc | — | Other | Series A | $23.6M | $83.7M | 2014 |
| Zipline Medical Inc | — | Other | Series B | $18.3M | $272.2M | 2009 |
| Alterg Inc | — | Other Health Care | Series A | $17.9M | $112.9M | 2012 |
| Trireme Medical Inc | — | Other Health Care | Series A | $14.7M | $153.4M | 2009 |
| Qool Therapeutics, Inc. | — | Pharma | Series A | $14.2M | $432.4M | 2015 |
Amir Belson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amir Belson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Siegel | 1 | 13 |
| Mark Wan | 1 | 10 |
| Stephen Reeders | 1 | 9 |
| FRED MOLL | 1 | 8 |
| WILLIAM DAI | 1 | 8 |
| Ross Jaffe | 1 | 7 |
| Myles Greenberg | 1 | 6 |
| Bosun Hau | 1 | 6 |
| J. Casey McGlynn | 1 | 5 |
| Nicholas Pappas | 1 | 4 |
| Elton Satusky | 1 | 4 |
| Greg Casciaro | 1 | 4 |
| Mark McKee | 1 | 4 |
| Beverly Huss | 1 | 4 |
| Charles Remsberg | 1 | 3 |
| Peng Cheng | 1 | 3 |
| Michael Lynn | 1 | 3 |
| Balaji Muralidhar | 1 | 3 |
| Lars Barfod | 1 | 2 |
| Todd Brinton | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.